1. Home
  2. FOLD vs PTRN Comparison

FOLD vs PTRN Comparison

Compare FOLD & PTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$14.19

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

PTRN

Pattern Group Inc.

N/A

Current Price

$11.92

Market Cap

3.0B

ML Signal

N/A

Company Overview

Basic Information
Metric
FOLD
PTRN
Founded
2002
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.0B
IPO Year
2007
2025

Fundamental Metrics

Financial Performance
Metric
FOLD
PTRN
Price
$14.19
$11.92
Analyst Decision
Buy
Strong Buy
Analyst Count
8
10
Target Price
$29.79
$19.89
AVG Volume (30 Days)
14.8M
866.6K
Earning Date
11-04-2025
02-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$598,704,000.00
$2,293,676,000.00
Revenue This Year
$21.49
$39.02
Revenue Next Year
$18.25
$24.87
P/E Ratio
N/A
N/A
Revenue Growth
21.28
67.86
52 Week Low
$5.51
$11.40
52 Week High
$14.36
$20.10

Technical Indicators

Market Signals
Indicator
FOLD
PTRN
Relative Strength Index (RSI) 91.10 N/A
Support Level $10.64 N/A
Resistance Level $11.14 N/A
Average True Range (ATR) 0.36 0.00
MACD 0.28 0.00
Stochastic Oscillator 96.46 0.00

Price Performance

Historical Comparison
FOLD
PTRN

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

About PTRN Pattern Group Inc.

Pattern Group Inc is an ecommerce accelerator, uses its technology platform, data science and a team of experts to drive growth for brands. The Company acquires inventory from brand partners to sell to consumers, enabling full control over content, pricing, logistics and customer service. Brand partners that contract with the Company operate in various industries including health and wellness, beauty and personal care, home and lifestyle, pet, sports and outdoors and consumer electronics.

Share on Social Networks: